Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Find Successful Magnificence Items for Sparkling Skin - 2Strength training is crucial after menopause. How to make the most of your workouts
- 3Single women risk rape and exploitation in search for better life in Europe
- 4A coup too far: Why Benin's rebel soldiers failed where others in the region succeeded
- 5‘Extraordinary’ Iron Age war trumpet uncovered in England
- Experience Is standing by: History's Most noteworthy Travelers
- What is the Insurrection Act? Can Trump really use the military to 'put an end' to Minneapolis ICE protests?
- 'Stranger Things' character guide: The nerds, the newcomers and the rest of the Season 5 cast
- Let them eat (Taylor Swift) cake: The baker turning A-listers into life-size desserts
- Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
- The most effective method to Decisively Plan Your Nursing Profession for the Best Compensation Results
- Instructions to Amplify Certifiable Experience While Chasing after an Internet Advertising Degree
- 'Zootopia 2' movie reviews: A heartwarming, hysterical and earnest 'ode to community'
- Bomb blast in packed Nigerian mosque kills five
